Efficacy of pemetrexed-based regimens in advanced non–small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review

Han BH, Yang LL, Wang X, Yao LD

OncoTargets and Therapy 2018, 11:2121-2129

Published Date: 12 April 2018